KCR S.A. and Tokyo CRO form strategic alliance

Sponsors gain geographical advantage with service expertise from across Europe, the USA and Asia in regards to clinical research.

Warsaw, March 16, 2010: Two leading full service contract research organizations (CROs), KCR S.A. and Tokyo CRO, Inc. today announced the formation of a strategic alliance strengthening their services in Europe, the United Stated and Asia providing sponsors with a global network. This alliance provides pharmaceutical, biotechnology and medical device companies with access to Europe, the US as well as Asia for clinical research.

Speaking on the strength of this alliance, Ryozo Hasegawa, Ph.D., Co-Founder and President of Tokyo CRO said, “As a full service CRO, we have established our presence across Japan, China and Korea. This alliance enables us to extend clinical trials to Europe and US.”

Mr. Marek Kiecana, Founder and Chairman of KCR S.A. added, “We have established our expertise across the EU and the USA as a top quality service CRO. Japan is a key market, as sponsors increasingly include Japan in drug development programs and it is imperative for us to establish our operations through experts like Tokyo CRO in this region. While both partners offer full-service CRO operations independently, our execution synergy is enhanced when operating together, rivaling the capability of any competing CRO.”

Notes to the Editor:

Tokyo CRO Inc. (www.cro.co.jp), a leading Japanese CRO, is headquartered in Tokyo, Japan, has offices in Tokyo, Osaka, Kobe, Sapporo and Fukuoka. The company has around 14 years of experience in the CRO business, has a growing presence in Eastern Asia through the establishment of Beijing CRO in China and Seoul CRO in Korea. Tokyo CRO provides comprehensive full services, including strategic planning for clinical development, monitoring, data management and biostatistics, post marketing surveillance, safety information management, medical writing, quality assurance and regulatory affairs for the pharmaceutical, biotechnology and medical device companies.

KCR S.A. (www.kcrcro.com) is headquartered in Poland (Warsaw) with their own staff in the Czech Republic, Slovakia, Ukraine, Lithuania, Latvia, Estonia, Bulgaria, Romania, Hungary, Russia, Serbia, Croatia and Slovenia.  KCR is the Expert CRO conducting clinical trials in Central and Eastern European countries (CEE) – The CEE is the best market for conducting clinical trials in terms of speed of recruitment and quality in Europe.  KCR is a preferred provider for several of the top ten global pharmaceutical and biotechnology companies from the USA and Europe. KCR also provides comprehensive full services for Phase II - IV clinical research, including clinical project management, clinical monitoring, safety/pharmaco-vigilance, medical affairs, regulatory and quality assurance for the pharmaceutical, biotechnology, nutritional and medical device companies.
 

For further details please contact:

Media Contact:

KCR:  Dr Anna Dryja  - anna.dryja@kcrcro.com 

Tokyo CRO: Keiji Komoriya  - k.komoriya.qc@cro.co.jp

Please see:

• Introduction of KCR & T-CRO-Mar032010